Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |